t-AUCB is a soluble epoxide hydrolase inhibitor (sEHI), suppressing human glioblastoma cell growth by activating NF-κB-p65. References: Gui Y, Li D, Chen J, Wang Y, Hu J, Liao C, Deng L, Xiang Q, Yang T, Du X, Zhang S, Xu D. Soluble epoxide hydrolase inhibitors, t-AUCB, downregulated miR-133 in a mouse model of myocardial infarction. Lipids Health Dis. 2018 May 29;17(1):129. doi: 10.1186/s12944-018-0780-y. PubMed PMID: 29843720; PubMed Central PMCID: PMC5975509.

纯度：≥98%

CAS：885012-33-9